A randomized clinical trial comparing point-of-care platelet function assays and bleeding time in healthy subjects treated with aspirin or clopidogrel

Platelets

Volumn 23, Issue 4, 2012, Pages 249-258

  Chen, Fabian ^a   Maridakis, Victor ^a   O'Neill, Edward A ^a   Beals, Chan ^a   Radziszewski, Waldemar ^a,b   De Lepeleire, Inge ^c   Van Dyck, Kristien ^c   Depré, Marleen ^d   Bolognese, James A ^e   De Hoon, Jan ^d   Jacquemin, Marc ^f  

^a MERCK RESEARCH LABORATORIES   (United States)

^b JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT   (United States)

^c Merck Sharp and Dohme   (Belgium)

^d UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^e Cytel Incorporated   (United States)

^f UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Aggregometry; Bleeding time; Multiplate ; Platelet aggregation; Platelet Function Analyzer ; VerifyNow

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL;

ADULT; ARTICLE; BLEEDING TIME; BLOOD CLOTTING PARAMETERS; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; EFFECT SIZE; FEMALE; HUMAN; HUMAN EXPERIMENT; LIGHT TRANSMISSION AGGREGOMETRY; MALE; NORMAL HUMAN; POINT OF CARE TESTING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; THROMBOCYTE FUNCTION;

ADULT; ARYL HYDROCARBON HYDROXYLASES; ASPIRIN; BLEEDING TIME; CROSS-OVER STUDIES; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; PLATELET FUNCTION TESTS; POINT-OF-CARE SYSTEMS; TICLOPIDINE; YOUNG ADULT;

EID: 84862897074     PISSN: 09537104     EISSN: 13691635     Source Type: Journal    
DOI: 10.3109/09537104.2011.604806     Document Type: Article

References (21)

1. Jin RC, Voetsch B, Loscalzo J. Endogenous mechanisms of inhibition of platelet function. Microcirculation 2005;12(3):247-258. (Pubitemid 40691822)
2. Arora R, Rai F. Atherothrombosis and the management of the vulnerable vascular patient. Am J Ther 2009; 16(1):24-34.
3. Rodgers RP, Levin J. A critical reappraisal of the bleeding time. Semin Thromb Hemost 1990;16(1):1-20. (Pubitemid 20049639)
4. Santilli F, Rocca B, De Cristofaro R, Lattanzio S, Pietrangelo L, Habib A, Pettinella C, Recchiuti A, Ferrante E, Ciabattoni G, et al. Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays: Implications for aspirin "resistance". J Am Coll Cardiol 2009;53(8):667-677.
5. Cuisset T, Frere C, Poyet R, Quilici J, Gaborit B, Bali L, Brissy O, Lambert M, Morange PE, Alessi MC, et al. Clopidogrel response: Head-to-head comparison of different platelet assays to identify clopidogrel non responder patients after coronary stenting. Arch Cardiovasc Dis 2010;103(1):39-45.
6. Hofer CK, Zollinger A, Ganter MT. Perioperative assessment of platelet function in patients under antiplatelet therapy. Expert Rev Med Devices 2010;7(5):625-637.
7. Breet NJ, van Werkum JW, Bouman HJ, Kelder JC, Ruven HJ, Bal ET, Deneer VH, Harmsze AM, van der Heyden JA, Rensing BJ, et al. Comparison of platelet function tests in predicting clinical outcome in patients undergoing coronary stent implantation. JAMA 2010;303(8):754-762.
8. Nicholson NS, Panzer-Knodle SG, Haas NF, Taite BB, Szalony JA, Page JD, Feigen LP, Lansky DM, Salyers AK. Assessment of platelet function assays. Am Heart J 1998;135(5 Pt. 2 Su):S170-S178.
9. Simon DI, Liu CB, Ganz P, Kirshenbaum JM, Piana RN, Rogers C, Selwyn AP, Popma JJ. A comparative study of light transmission aggregometry and automated bedside platelet function assays in patients undergoing percutaneous coronary intervention and receiving abciximab, eptifibatide, or tirofiban. Catheter Cardiovasc Interv 2001;52(4):425-432. (Pubitemid 32275029)
10. van Werkum JW, Hackeng CM, de Korte FI, Verheugt FW, Ten Berg JM. Point-of-care platelet function testing in patients undergoing PCI: Between a rock and a hard place. Neth Heart J 2007;15(9):299-305. (Pubitemid 350075124)
11. Patrono C, Garcia Rodriguez LA, Landolfi R, Baigent C. Low-dose aspirin for the prevention of atherothrombosis. N Engl J Med 2005;353(22):2373-2383. (Pubitemid 41713749)
12. Herbert JM, Savi P. P2Y12, a new platelet ADP receptor, target of clopidogrel. Semin Vasc Med 2003;3(2):113-122.
13. Sibbing D, Braun S, Jawansky S, Vogt W, Mehilli J, Schomig A, Kastrati A, von Beckerath N. Assessment of ADP-induced platelet aggregation with light transmission aggregometry and multiple electrode platelet aggregometry before and after clopidogrel treatment. Thromb Haemost 2008;99(1):121-126.
14. Homoncik M, Jilma B, Hergovich N, Stohlawetz P, Panzer S, Speiser W. Monitoring of aspirin (ASA) pharmacodynamics with the platelet function analyzer PFA-100. Thromb Haemost 2000;83(2):316-321. (Pubitemid 30093238)
15. Kundu SK, Heilmann EJ, Sio R, Garcia C, Davidson RM, Ostgaard RA. Description of an in vitro platelet function analyzer-PFA-100. Semin Thromb Hemost 1995;21(Suppl. 2):106-112.
16. Mammen EF, Comp PC, Gosselin R, Greenberg C, Hoots WK, Kessler CM, Larkin EC, Liles D, Nugent DJ. PFA-100 system: A new method for assessment of platelet dysfunction. Semin Thromb Hemost 1998;24(2):195-202. (Pubitemid 28180831)
17. Jakubowski JA, Payne CD, Li YG, Brandt JT, Small DS, Farid NA, Salazar DE, Winters KJ. The use of the VerifyNow P2Y12 point-of-care device to monitor platelet function across a range of P2Y12 inhibition levels following prasugrel and clopidogrel administration. Thromb Haemost 2008;99(2):409-415. (Pubitemid 351230973)
18. Karon BS, Wockenfus A, Scott R, Hartman SJ, McConnell JP, Santrach PJ, Jaffe AS. Aspirin responsiveness in healthy volunteers measured with multiple assay platforms. Clin Chem 2008;54(6):1060-1065. (Pubitemid 351793414)
19. Chanarin I. Platelet function test. In: Chanarin I, editor. Laboratory haematology: An account of laboratory techniques. Edinburgh: Churchill Livingstone; 1989. pp 371-399.
20. Siller-Matula JM, Gouya G, Wolzt M, Jilma B. Cross validation of the multiple electrode aggregometry. A prospective trial in healthy volunteers. Thromb Haemost 2009;102(2):397-403.
21. Lordkipanidze M, Pharand C, Schampaert E, Turgeon J, Palisaitis DA, Diodati JG. A comparison of six major platelet function tests to determine the prevalence of aspirin resistance in patients with stable coronary artery disease. Eur Heart J 2007;28(14):1702-1728.